All Stories

  1. Reference Standard for Validation of Age-Related Macular Degeneration Screening Algorithms
  2. Reduction in Pigment Epithelial Detachment Thickness with Faricimab vs Aflibercept 2 mg During Head-to-Head Dosing in TENAYA/LUCERNE
  3. ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR STAGES 3 AND 4 PROLIFERATIVE SICKLE CELL RETINOPATHY RESULTS IN IMPROVED ANATOMICAL AND VISUAL OUTCOMES
  4. Blind Spots: Patient Knowledge and Practices around Ocular Complications in Sickle Cell Disease
  5. LONGITUDINAL OUTCOMES STUDY OF SUTURELESS SCLERAL-FIXATED INTRAOCULAR LENSES
  6. Anatomic Control with Faricimab versus Aflibercept in the YOSEMITE/RHINE Trials in Diabetic Macular Edema
  7. Response of Diabetic Macular Edema to Anti-VEGF Medications Correlates with Improvement in Macular Vessel Architecture Measured with OCT Angiography
  8. Ocular and Systemic Risk Factors for Disease Worsening Among Patients with NPDR
  9. The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
  10. METformin FOR the MINimization of Geographic Atrophy Progression (METforMIN) – A Randomized Trial
  11. Federated Learning in Diagnosing Age-Related Macular Degeneration
  12. Optimizing the OCTA layer fusion option for deep learning classification of diabetic retinopathy
  13. Federated Learning for Diagnosis of Age-related Macular Degeneration
  14. COMPARATIVE ANALYSIS OF OCT AND OCT ANGIOGRAPHY CHARACTERISTICS IN EARLY DIABETIC RETINOPATHY
  15. Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models
  16. Normalized Blood Flow Index in Optical Coherence Tomography Angiography Provides a Sensitive Biomarker of Early Diabetic Retinopathy
  17. Multi-fusion strategies for deep learning artery and vein segmentation in OCT angiography
  18. Comparison of AI and dilated eye exams for the detection of diabetic retinopathy
  19. Simulation of long-term impact of intravitreal anti-VEGF therapy on patients with severe non-proliferative diabetic retinopathy
  20. Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry
  21. Rhegmatogenous retinal detachment surgery: A review
  22. Automated Region of Interest Selection Improves Deep Learning-Based Segmentation of Hyper-Reflective Foci in Optical Coherence Tomography Images
  23. AVA-Net: an open-source deep learning network for arterial-venous area segmentation in OCT angiography
  24. Contrastive learning-based pretraining improves representation and transferability of diabetic retinopathy classification models
  25. MF-AV-Net: an open-source deep learning network with multimodal fusion options for artery-vein segmentation in OCT angiography
  26. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY REVEALS ROD PHOTORECEPTOR DEGENERATION in EARLY DIABETIC RETINOPATHY
  27. From Data to Deployment
  28. Comparative feature analysis in OCT and OCT angiography of diabetic retinopathy
  29. Quantitative features for objective assessment of OCT angiography
  30. Pivotal Evaluation of an Artificial Intelligence System for Autonomous Detection of Referrable and Vision-Threatening Diabetic Retinopathy
  31. Imaging and artificial intelligence for progression of age-related macular degeneration
  32. Bilateral Macular Schisis in a Woman
  33. Probabilistic Forecasting of Anti-VEGF Treatment Frequency in Neovascular Age-Related Macular Degeneration
  34. Closure of Full-Thickness Macular Holes Associated with Macular Edema with Medical Therapy
  35. Prevention of Severe Nonproliferative Diabetic Retinopathy Progression With More at Stake Than Visual Acuity
  36. Deep learning artery-vein classification in OCT angiography
  37. Longitudinal Assessment of Retinal Thinning in Adults With and Without Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography
  38. Sickle Cell Retinopathy
  39. AV-Net: deep learning for fully automated artery-vein classification in optical coherence tomography angiography
  40. Reply
  41. Transfer Learning for Automated OCTA Detection of Diabetic Retinopathy
  42. VASCULAR COMPLEXITY ANALYSIS IN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF DIABETIC RETINOPATHY
  43. Quantitative analysis of vascular complexity in OCTA of diabetic retinopathy
  44. Deep learning for objective OCTA detection of diabetic retinopathy
  45. Retinal Vein Occlusions Preferred Practice Pattern®
  46. Idiopathic Macular Hole Preferred Practice Pattern®
  47. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®
  48. Idiopathic Epiretinal Membrane and Vitreomacular Traction Preferred Practice Pattern®
  49. ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS
  50. QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES FOR OBJECTIVE CLASSIFICATION AND STAGING OF DIABETIC RETINOPATHY
  51. Diabetic Retinopathy Preferred Practice Pattern®
  52. Age-Related Macular Degeneration Preferred Practice Pattern®
  53. Posterior Vitreous Detachment, Retinal Breaks, and Lattice Degeneration Preferred Practice Pattern®
  54. “Iodine Allergy” and the Use of Povidone Iodine for Endophthalmitis Prophylaxis
  55. AMPLITUDE LOSS OF THE HIGH-FREQUENCY FLICKER ELECTRORETINOGRAM IN EARLY DIABETIC RETINOPATHY
  56. Relating retinal blood flow and vessel morphology in sickle cell retinopathy
  57. Contrast sensitivity is associated with outer‐retina thickness in early‐stage diabetic retinopathy
  58. Hypotony and the Argus II retinal prosthesis: causes, prevention and management
  59. Simulating vascular leakage on optical coherence tomography angiography using an overlay technique with corresponding thickness maps
  60. Supervised Machine Learning Based Multi-Task Artificial Intelligence Classification of Retinopathies
  61. Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies
  62. Bilateral Blurry Vision in a Human Leukocyte Antigen B27–Positive Man
  63. Electrophysiological and pupillometric measures of inner retina function in nonproliferative diabetic retinopathy
  64. Fully automated geometric feature analysis in optical coherence tomography angiography for objective classification of diabetic retinopathy
  65. Differential Artery–Vein Analysis Improves the Performance of OCTA Staging of Sickle Cell Retinopathy
  66. OCT feature analysis guided artery-vein differentiation in OCTA
  67. Quantitative artery-vein analysis in optical coherence tomography angiography of diabetic retinopathy
  68. Management of severe retinal detachment
  69. Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration
  70. Diagnostic accuracy and reliability of retinal pathology using the Forus 3nethra fundus camera compared to ultra wide-field imaging
  71. Progression of Geographic Atrophy in Age-related Macular Degeneration
  72. Macular Vitelliform-Like Lesion in an Eye With Chronic Retinal Detachment
  73. Color Fundus Image Guided Artery-Vein Differentiation in Optical Coherence Tomography Angiography
  74. Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
  75. COMPARISON OF VISUAL AND ANATOMICAL OUTCOMES OF EYES UNDERGOING TYPE I BOSTON KERATOPROSTHESIS WITH COMBINATION PARS PLANA VITRECTOMY WITH EYES WITHOUT COMBINATION VITRECTOMY
  76. Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International Study
  77. Cyst Masquerading as Inadvertent Bleb After a Scleral-Fixated Intraocular Lens in Marfan Syndrome: A Case Report
  78. Analysis of Retinal Thinning Using Spectral-domain Optical Coherence Tomography Imaging of Sickle Cell Retinopathy Eyes Compared to Age- and Race-Matched Control Eyes
  79. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti–Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema
  80. Combining ODR and Blood Vessel Tracking for Artery–Vein Classification and Analysis in Color Fundus Images
  81. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti–Vascular Endothelial Growth Factor Medications
  82. Automated classification and quantitative analysis of arterial and venous vessels in fundus images
  83. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
  84. Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy
  85. Cholesterol Crystals Secondary to Coats-Like Response With Retinitis Pigmentosa
  86. Macula Society Collaborative Retrospective Study of Ocriplasmin for Symptomatic Vitreomacular Adhesion
  87. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis
  88. YAG Laser Vitreolysis—Is It as Clear as It Seems?
  89. Computer-aided classification of sickle cell retinopathy using quantitative features in optical coherence tomography angiography
  90. Acute Vision Loss and Bilateral Macular Lesions
  91. Method for quantitative assessment of retinal vessel tortuosity in optical coherence tomography angiography applied to sickle cell retinopathy
  92. Profound Macular Ischemia on Optical Coherence Tomography Angiography in Severe Diabetic Retinopathy
  93. Pupillary responses in non-proliferative diabetic retinopathy
  94. Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography
  95. Headaches and Foggy Vision in a 21-Year-Old Woman
  96. The Effects of Diabetic Retinopathy Stage and Light Flicker on Inner Retinal Oxygen Extraction Fraction
  97. Alterations in Retinal Layer Thickness and Reflectance at Different Stages of Diabetic Retinopathy by En Face Optical Coherence Tomography
  98. Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data
  99. Worldwide Argus II implantation: recommendations to optimize patient outcomes
  100. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study
  101. Chronic Visual Disturbance in a Young Healthy Man
  102. Painful Red Eye in a Woman in Her 70s
  103. Cross-Sectional analysis of neurocognitive function, retinopathy, and retinal thinning by Spectral-Domain optical coherence tomography in sickle cell patients
  104. Enface Thickness Mapping and Reflectance Imaging of Retinal Layers in Diabetic Retinopathy
  105. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial
  106. Outcome of Treatment of Uveitic Macular Edema
  107. Blurred Vision in a Woman Who Had Sphenoid Wing Meningioma
  108. Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment
  109. New Pigmented Lesion Over a Site of Tumor Treatment
  110. Inner and Outer Retinal Thickness Mapping of Nonproliferative Diabetic Retinopathy by Spectral-Domain Optical Coherence Tomography
  111. Subconjunctival Hemorrhages and Retinal Vascular Abnormalities
  112. Conjunctival microvascular haemodynamics in sickle cell retinopathy
  113. One year results of a phase 1 study of the safety and tolerability of combination therapy using sustained release intravitreal triamcinolone acetonide and ranibizumab for subfoveal neovascular AMD
  114. Sudden-Onset Paracentral Vision Loss
  115. Wavefront Error Correction with Adaptive Optics in Diabetic Retinopathy
  116. Optical Coherence Tomography Retinal Thickness and Volume Measurements in X-Linked Retinoschisis
  117. Collaborative Retrospective Macula Society Study of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
  118. Cotton-Wool Spots and Retinal Hemorrhages
  119. Neural Constraints on Visual Acuity in Proliferative Diabetic Retinopathy
  120. A Method for En Face OCT Imaging of Subretinal Fluid in Age-Related Macular Degeneration
  121. INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR FOR CHOROIDAL NEOVASCULARIZATION IN OCULAR HISTOPLASMOSIS
  122. Smudge in My Vision
  123. Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease
  124. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
  125. Peripapillary Retinal Nerve Fiber Layer Thickness in Sickle-Cell Hemoglobinopathies Using Spectral-Domain Optical Coherence Tomography
  126. MULTIFOCAL RETINAL ASTROCYTIC HAMARTOMAS
  127. Age-Related Macular Degeneration
  128. Ophthalmic manifestations of sickle cell disease
  129. EN FACE SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY OUTER RETINAL ANALYSIS AND RELATION TO VISUAL ACUITY
  130. Object Frequency Characteristics of Visual Acuity
  131. Reply
  132. Feasibility of a Method for En Face Imaging of Photoreceptor Cell Integrity
  133. Structural and Functional Correlation in Sickle Cell Retinopathy Using Spectral-Domain Optical Coherence Tomography and Scanning Laser Ophthalmoscope Microperimetry
  134. Sustained-Release Intravitreal Liquid Drug Delivery Using Triamcinolone Acetonide for Cystoid Macular Edema in Retinal Vein Occlusion
  135. Central Macular Splaying and Outer Retinal Thinning in Asymptomatic Sickle Cell Patients by Spectral-Domain Optical Coherence Tomography
  136. Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
  137. A COMPARISON OF HYPOXIA-INDUCIBLE FACTOR-α IN SURGICALLY EXCISED NEOVASCULAR MEMBRANES OF PATIENTS WITH DIABETES COMPARED WITH IDIOPATHIC EPIRETINAL MEMBRANES IN NONDIABETIC PATIENTS
  138. Chronic Coccidioidomycosis Endophthalmitis without Concomitant Systemic Involvement: A Clinicopathological Case Report
  139. REGRESSION OF CHOROIDAL NEOVASCULARIZATION AFTER VITRECTOMY FOR POSTINJECTION ENDOPHTHALMITIS
  140. Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study
  141. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 2: 810-Nanometer Laser to Eyes With Drusen: Bilaterally Eligible Patients
  142. Reply
  143. Update on Laser Treatment of Diabetic Macular Edema
  144. Pharmacotherapy of age-related macular degeneration
  145. A Pilot Study of Fourier-Domain Optical Coherence Tomography of Retinal Dystrophy Patients
  146. Optical coherence tomography findings in paraneoplastic pseudovitelliform lesions in melanoma-associated retinopathy
  147. Primary transpupillary thermotherapy for small choroidal melanomas
  148. Presumed ocular tuberculosis presenting as a branch retinal vein occlusion in the absence of retinal vasculitis or uveitis
  149. Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF
  150. Xanthogranuloma of the Iris Simulating Melanoma in an Adult
  151. New treatments for neovascular acute macular degeneration
  152. Pharmacotherapy for neovascular age-related macular degeneration: clinical trials and the art of medicine
  153. MACULAR DEGENERATION: THE LATEST IN CURRENT MEDICAL MANAGEMENT
  154. GROUP B STREPTOCOCCAL ENDOGENOUS ENDOPHTHALMITIS IN A NEONATE
  155. Prophylactic Treatment of Age-Related Macular Degeneration Report Number 1: 810-Nanometer Laser to Eyes with Drusen. Unilaterally Eligible Patients
  156. Photodynamic Therapy for Choroidal Neovascularisation Secondary to Inflammatory Chorioretinal Disease
  157. ONE-YEAR RESULTS OF A PILOT STUDY USING ORAL 13-CIS RETINOIC ACID AS A TREATMENT FOR SUBFOVEAL PREDOMINANTLY OCCULT CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION
  158. Hastening Choroidal Neovascularization: The Irony of Prophylactic Laser in Unilateral Eyes With High-Risk Drusen
  159. Sequential induction of angiogenic growth factors by TNF-α in choroidal endothelial cells
  160. Neuropilin-1 Expression by Endothelial Cells and Retinal Pigment Epithelial Cells in Choroidal Neovascular Membranes
  161. NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: ROUNDTABLE
  162. SCOTOMAS OF AGE-RELATED MACULAR DEGENERATION DETECTED AND CHARACTERIZED BY MEANS OF A NOVEL THREE-DIMENSIONAL COMPUTER-AUTOMATED VISUAL FIELD TEST
  163. Atypical Presentation of Multiple Evanescent White Dot Syndrome Involving Granular Lesions of Varying Size
  164. Outcomes of 140 Consecutive Cases of 25-Gauge Transconjunctival Surgery for Posterior Segment Disease
  165. Bartonella henselae infection presenting as a unilateral panuveitis simulating Vogt-Koyanagi-Harada syndrome
  166. Accumulation of NH2-Terminal Fragment of Connective Tissue Growth Factor in the Vitreous of Patients With Proliferative Diabetic Retinopathy
  167. Posterior uveal effusion syndrome after trabeculectomy in an eye with ocular venous congestion
  168. Diagnostic and Therapeutic Challenges
  169. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia
  170. Episcleral plaque 125I radiotherapy with episcleral LCF hyperthermia: A prospective randomized trial
  171. Indocyanine green angiography in chorioretinal diseases: indications and interpretation
  172. Diabetic macular edema: review and update
  173. Macular disease
  174. Photodynamic therapy for choroidal neovascular disease: photosensitizers and clinical trials
  175. Update on pseudophakic cystoid macular edema treatment options
  176. Uveal metastasis 43 years after resection of bronchogenic carcinoid
  177. COMPARISON OF NONMYDRIATIC DIGITIZED VIDEO FUNDUS IMAGES WITH STANDARD 35-MM SLIDES TO SCREEN FOR AND IDENTIFY SPECIFIC LESIONS OF AGE-RELATED MACULAR DEGENERATION
  178. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy
  179. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss
  180. A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss
  181. Vitrectomy and membrane dissection surger: Author reply
  182. Exudative retinal detachment in relapsing polychondritis
  183. PARS PLANA VITRECTOMY FOR EPIRETINAL MEMBRANE SECONDARY TO CAT SCRATCH NEURORETINITIS
  184. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic th...
  185. Radioactive plaque therapy for metastatic choroidal carcinoma
  186. Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: i. ophthalmic outcomes submacular surgery trials pilot study report numb...
  187. Vitreoretinal surgery through multifocal intraocular lenses compared with monofocal intraocular lenses in fluid-filled and air-filled rabbit eyes
  188. A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy
  189. Retina Vitreous-Macula
  190. Iatrogenic Choroidal Neovascularization
  191. Multiple evanescent white dot syndrome in older patients
  192. PARANEOPLASTIC RETINAL SYNDROMES
  193. Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis
  194. Macular Hole Surgery Using Thrombin-Activated Fibrinogen and Selective Removal of the Internal Limiting Membrane
  195. MACULAR HOLE SURGERY USING THROMBIN-ACTIVATED FIBRINOGEN AND SELECTIVE REMOVAL OF THE INTERNAL LIMITING MEMBRANE
  196. Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS report no. 6
  197. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled COMS report no. 9
  198. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings COMS report no. 10
  199. SYMPTOMATIC AGE-RELATED MACULAR DEGENERATION IN ASIAN PATIENTS
  200. Hydrogel Exoplant Fragmentation 10 Years After Scleral Buckling Surgery
  201. Indocyanine Green Angiography-guided Photocoagulation of Choroidal Neovascularization Associated With Retinal Pigment Epithelial Detachment
  202. Ultrapower surgical drill system evaluation
  203. Microbiologic Factors and Visual Outcome in the Endophthalmitis Vitrectomy Study
  204. Retained Lens Material Masquerading as a Growing, Pigmented Iris Tumor
  205. Ciliary Body Endophotocoagulation during Pars Plana Vitrectomy in Eyes with Vitreoretinal Disorders and Concomitant Uncontrolled Glaucoma
  206. Recent developments in indocyanine green angiography
  207. Postoperative Hypopyon After Intravitreal Bovine Thrombin for Macular Hole Surgery
  208. Anaphylactic Shock Following Indocyanine Green Angiography
  209. CLINICOPATHOLOGIC FEATURES OF INDOCYANINE GREEN ANGIOGRAPHY-IMAGED, SURGICALLY EXCISED CHOROIDAL NEOVASCULAR MEMBRANES
  210. RETINOBLASTOMA RECURRENCE AFTER IODINE 125 PLAQUE APPLICATION
  211. Submacular Hemorrhage Removal
  212. Selective Use of Indocyanine Green Angiography for Occult Choroidal Neovascularization
  213. Correspondence
  214. Indocyanine Green Angiography
  215. Subretinal Hemorrhage
  216. The Role of Gravity in Gentamicin-Induced Toxic Effects in a Rabbit Model
  217. Candidal Retinitis in a Gynecologic Patient
  218. Pilot Trial of Transscleral Diode Laser Retinopexy in Retinal Detachment Surgery-Reply
  219. Improved Visual Results after Surgical Repair of Cytomegalovirus-related Retinal Detachments
  220. ADENOMA OF THE NONPIGMENTED CILIARY EPITHELIUM
  221. Aminoglycoside Toxicity in the Treatment of Endophthalmitis
  222. Foveomacular Dystrophy
  223. A New Syndrome of Myelinated Nerve Fibers, Vitreoretinopathy, and Skeletal Malformations
  224. Laser Treatment of Choroidal Neovascularization in Patients With Angioid Streaks
  225. Pilot Trial of Transscleral Diode Laser Retinopexy in Retinal Detachment Surgery
  226. Intraocular Tissue Plasminogen Activator Concentrations after Subconjunctival Delivery
  227. VISUAL ABNORMALITIES ASSOCIATED WITH HIGH-ENERGY MICROWAVE EXPOSURE
  228. Late-onset Sterile Endophthalmitis After Molteno Tube Implantation
  229. Successful Treatment of Gram-negative Endophthalmitis With Intravitreous Ceftazidime
  230. ATYPICAL PARAFOVEAL TELANGIECTASIS WITH SUBSEQUENT ANTERIOR AND POSTERIOR SEGMENT NEOVASCULARIZATION
  231. Macular Hole Formation Following Laser Photocoagulation of Choroidal Neovascular Membranes in a Patient With Presumed Ocular Histoplasmosis
  232. What to tell the patient with optic neuritis about multiple sclerosis
  233. Intraocular Penetration of Topical Tissue Plasminogen Activator
  234. Anterior Granulomatous Uveitis in Patients with Multiple Sclerosis
  235. Brown-McLean Syndrome
  236. Penetrating Ocular Injury From Contaminated Eating Utensils
  237. A Retinal Pigment Epithelium Tear in a Patient With Angioid Streaks
  238. Assessment of Intraocular Pressure in Vitrectomized Gas-Containing Eyes
  239. Retinal Pigment Epithelium Tear in a Diabetic Patient With Exudative Retinal Detachment Following Panretinal Photocoagulation and Filtration Surgery
  240. Idiopathic Sclerochoroidal Calcification
  241. Comparison of the Challenger Digital Applanation Tonometer and the Goldmann Applanation Tonometer
  242. Ultraviolet light absorbing pseudophakos